Pirfenidone 801 MG Oral Tablet [Esbriet]

Name: Pirfenidone 801 MG Oral Tablet Price Comparison: Uses, Dosage, Form & Side Effects
Creator: gmedication.com
Published: 2021-11-01T10:10:10+00:00

What was the prescribed dosage?

Here is the some steps to help you to save money on Pirfenidone 801 MG Oral Tablet [Esbriet] purchase.

Read drug prescription

What is pirfenidone 801 MG Oral Tablet [Esbriet]
Pirfenidone 801 MG Oral Tablet [Esbriet] side effects
Pirfenidone 801 MG Oral Tablet [Esbriet] dosing

Select the most affordable brand or generic drug
Frequently asked Questions

Who should not take pirfenidone 801 MG Oral Tablet [Esbriet]?
What other drugs will affect pirfenidone 801 MG Oral Tablet [Esbriet]?
How should I take pirfenidone 801 MG Oral Tablet [Esbriet]?

Pirfenidone 801 MG Oral Tablet [Esbriet] reviews

Read drug prescription

What is pirfenidone 801 MG Oral Tablet [Esbriet]

pirfenidone 801 MG Oral Tablet [Esbriet] is used to treat a lung disease called idiopathic pulmonary fibrosis. IPF causes scar tissue to form deep within your lungs. The scar tissue thickens and becomes stiff or thick over time, which can make it harder for your lungs to work. Decreased lung function can make it hard for you to breathe. Other medical problems can occur when your brain, heart, and other organs do not get enough oxygen.
The cause of IPF is often unknown, but this condition is a progressive disease that can be fatal. Pirfenidone 801 MG Oral Tablet [Esbriet] is not a cure for IPF, but this medicine may slow the progress of this disease.
pirfenidone 801 MG Oral Tablet [Esbriet] may also be used for purposes not listed in pirfenidone 801 MG Oral Tablet [Esbriet] guide.

Pirfenidone 801 MG Oral Tablet [Esbriet] side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using pirfenidone 801 MG Oral Tablet [Esbriet] and call your doctor at once if you have:

severe ongoing stomach pain, vomiting, diarrhea;
burning or pain in your esophagus or throat;
easy bruising or bleeding (nosebleeds, bleeding gums); or
liver problems--nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Common side effects may include:

nausea, vomiting, loss of appetite;
stomach pain, heartburn, upset stomach;
diarrhea;
headache, dizziness, tired feeling;
weight loss;
cold symptoms such as stuffy nose, sneezing, sore throat;
sleep problems (insomnia);
joint pain; or
abnormal liver function tests.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)

Pirfenidone 801 MG Oral Tablet [Esbriet] dosing

Usual Adult Dose for Idiopathic Pulmonary Fibrosis:

Initial dose:
-Days 1 to 7: 267 mg orally three times a day
-Days 8 to 14: 534 mg (two capsules) orally three times a day
Maintenance/Maximum dose (Day 15 onward): 801 mg (three capsules) orally three times a day
Comments:
-Take with food to reduce nausea and dizziness.
-Doses should be taken at the same time each day.
Use: Idiopathic pulmonary fibrosis (IPF)

Active ingredients: pirfenidone

Select the most affordable brand or generic drug

Strength	Quantity	Price, USD	Country
Esbriet 267 MG Oral Capsule
Esbriet 267 MG Oral Tablet
Pirespa
Pirfenidone
200 mg	30	$56.00	Canada, India, NZ, Singapore, Turkey, UK, USA
200 mg	30	$64.00	Australia, Canada, India, Mauritius, NZ, Singapore, Turkey, UK, USA
200 mg	90	$174.00	Australia, Canada, India, NZ, Singapore, Turkey, UK, USA
pirfenidone 267 MG Oral Capsule
pirfenidone 267 MG Oral Tablet

References

Dailymed."Pirfenidone: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
Dailymed."Esbriet (pirfenidone) capsule esbriet (pirfenidone) tablet, coated [genentech, inc.]". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
"Pirfenidone". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).

Pirfenidone 801 MG Oral Tablet [Esbriet] - Frequently asked Questions

Can Pirfenidone 801 MG Oral Tablet [Esbriet] be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

Who should not take pirfenidone 801 MG Oral Tablet [Esbriet]?

You should not use pirfenidone 801 MG Oral Tablet [Esbriet] if you are allergic to it.

To make sure pirfenidone 801 MG Oral Tablet [Esbriet] is safe for you, tell your doctor if you have:

liver disease;
kidney disease;
a stomach disorder such as gastroesophageal reflux disease or slow digestion; or
if you smoke.

FDA pregnancy category C. It is not known whether pirfenidone 801 MG Oral Tablet [Esbriet] will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.

It is not known whether pirfenidone 801 MG Oral Tablet [Esbriet] passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.

What other drugs will affect pirfenidone 801 MG Oral Tablet [Esbriet]?

Other drugs may interact with pirfenidone 801 MG Oral Tablet [Esbriet], including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.

How should I take pirfenidone 801 MG Oral Tablet [Esbriet]?

Your doctor will perform blood tests to make sure you do not have conditions that would prevent you from safely using pirfenidone 801 MG Oral Tablet [Esbriet].

Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.

pirfenidone 801 MG Oral Tablet [Esbriet] should be taken with food to help decrease nausea or dizziness.

pirfenidone 801 MG Oral Tablet [Esbriet] is usually taken 3 times per day. Your dose needs will change over the first 15 days of your treatment.

For the first week, you will take only 1 capsule at a time.
During the second week, you will take 2 capsules at a time.
From the third week on, you will take 3 capsules at a time.

You must follow this 2-week "dose escalation" schedule when you start taking pirfenidone 801 MG Oral Tablet [Esbriet], or if you start taking the medicine again after not taking it for 14 days or longer. Follow your doctor's dosing instructions very carefully.

If you do stop taking pirfenidone 801 MG Oral Tablet [Esbriet] for any reason, talk with your doctor before restarting the medicine.

You may need frequent medical tests to be sure pirfenidone 801 MG Oral Tablet [Esbriet] is not causing harmful effects on your liver. Your next few doses may be delayed or reduced based on the results of these tests.

Store at room temperature away from moisture and heat. Keep the bottle tightly closed when not in use.

Can Pirfenidone 801 MG Oral Tablet [Esbriet] be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can Pirfenidone 801 MG Oral Tablet [Esbriet] be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

Reviews

Following the study conducted by gmedication.com on Pirfenidone 801 MG Oral Tablet [Esbriet], the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Pirfenidone 801 MG Oral Tablet [Esbriet]. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.